Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience

Viktoria Puxkandl; Theresa Bangerl; Kathrin Hanfstingl; Emmanuella Guenova; Wolfram Hoetzenecker; Sabine Altrichter

doi:10.1016/j.waojou.2022.100654

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience

Viktoria Puxkandl
, Theresa Bangerl
, Kathrin Hanfstingl
, Emmanuella Guenova
, Wolfram Hoetzenecker
, Sabine Altrichter

Department of Dermatology and Venereology

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	100654
Journal	The World Allergy Organization journal
Volume	15
Issue number	6
DOIs	https://doi.org/10.1016/j.waojou.2022.100654
Publication status	Published - Jun 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302087 Venereology
302011 Dermatology

Access to Document

10.1016/j.waojou.2022.100654

Cite this

@article{aa84bab72e3247af91f9a5df071895b4,

title = "Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience",

author = "Viktoria Puxkandl and Theresa Bangerl and Kathrin Hanfstingl and Emmanuella Guenova and Wolfram Hoetzenecker and Sabine Altrichter",

note = "{\textcopyright} 2022 The Author(s).",

year = "2022",

month = jun,

doi = "10.1016/j.waojou.2022.100654",

language = "English",

volume = "15",

journal = "The World Allergy Organization journal",

issn = "1939-4551",

number = "6",

}

TY - JOUR

T1 - Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience

AU - Puxkandl, Viktoria

AU - Bangerl, Theresa

AU - Hanfstingl, Kathrin

AU - Guenova, Emmanuella

AU - Hoetzenecker, Wolfram

AU - Altrichter, Sabine

PY - 2022/6

Y1 - 2022/6

UR - https://www.scopus.com/pages/publications/85131439035

U2 - 10.1016/j.waojou.2022.100654

DO - 10.1016/j.waojou.2022.100654

M3 - Article

C2 - 35611049

SN - 1939-4551

VL - 15

JO - The World Allergy Organization journal

JF - The World Allergy Organization journal

IS - 6

M1 - 100654

ER -

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this